Dr. Alexandru-Ioan Voda
Alexandru-Ioan Voda, D.Phil. is the CEO of The Cat Health Company, a company focused on cat health. He is focused on Regenerative Medicine, Bioinformatics, and Biotech and is passionate about all flavors of biomedical science, wet lab, computational, and basic research.
He considers himself a Coding aficionado, knowledgeable in data structures and algorithms, fluent in Python, R, and Bash, and several other languages.
Alex has expertise in computational methods for predicting disease targets. The Cat Health Company, where Alex is CEO, is dedicated to advancing cat health through innovative approaches and technologies. He has assembled a team of credentialed doctors (University of Oxford & EU-based pharmaceutical experts) to repurpose drugs for feline age-related diseases.
Additionally, Alex is the Cofounder of Cat Aging Diagnostics, a project focused on cat aging research and diagnostics. His work involved cutting-edge research in the field of Molecular and Cellular Medicine at the University of Oxford, where he earned his Ph.D. in 2022.
He earned his Bachelor’s Degree of Science in Biomedical Sciences with Industrial Experience in 2018 from the University of Manchester. In 2014, he earned his Diploma de Bacalaureat in Mathematics and Computer Science from the Colegiul National Sfantul Sava Bucuresti.
Previously, Alex was the Scientific Project Manager at Genevia Technologies, a Finnish CRO that specialized in delivering diverse bioinformatics solutions. Their mission is to facilitate the use of high-throughput genetic measurements and biological big data in life science companies and research institutions.
In 2015, Alex worked as a Summer Lab Intern at Fundeni Clinical Institute where he worked as an intern under the supervision of Prof. Liliana Paslaru. He has been trained with and used several techniques in investigations of possible liver cancer biomarkers.
In 2016, he moved to Reno, Nevada to work as Research Assistant at the University of Nevada. He started with a laboratory project aiming to identify genes involved in the development and aging of C. elegans. But he soon took on two extra computational biology projects. His work on one of the projects gained him a co-authorship on a BMC Genomics study while still an undergraduate, which was a rare accomplishment for his age. Read Global accumulation of circRNAs during aging in Caenorhabditis elegans.
In 2016, Alex cofounded the Manchester Undergraduate Journal of Biological Sciences. His team of 10 editors has been successful in networking with professors around the world to provide constructive feedback to the submitted drafts from undergrads. The topics ranged from molecular biology and bioethics to neuroscience and biophysics. In 2018, he retired from the team to focus on his research work.
In 2018, Alex received prestigious research funding from the Kennedy Trust to do his Doctoral Research and study the genetics of inflammatory bowel disease using novel technologies at the Kennedy Institute of Rheumatology, where he earned his D.Phil in 2022. During his doctoral studies, he discovered and published new computational ways of predicting disease targets. In 2023, he became a Researcher at the NDORMS, University of Oxford.
Alex was invited Speaker at the Longevity Summit Dublin 2024.
Watch the U.S. Transhumanist Party Virtual Enlightenment Salon with Alexandru Ioan Voda.
Visit his LinkedIn profile, ResearchGate profile, and Google Scholar page. Follow him on Facebook, GitHub, Instagram, YouTube, and Twitter.
